Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK)

Overview of attention for article published in Arthritis Research & Therapy, April 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

news: 1 news outlet

twitter: 1 X user

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 87 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

IV to SC Switch OK for Orencia in RA

MedPage Today, 23 Apr 2016

Action Points 94% of rheumatoid arthritis (RA) patients with low disease activity (LDA) were still in LDA 28 days after…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.